ANTITUMOR CHEMOTHERAPY IN COMBINED TREATMENT OF PATIENTS WITH CANCER OF THE LARYNX AND HYPOPHARYNX. Voprosy onkologii, v. 64, n. 5, p. 607–611, 1 May2018.